Article
Functional characterization of CYP2D6 enhancer polymorphisms.
Human molecular genetics - 15 Mar 2015
Wang Danxin, Papp Audrey C, Sun Xiaochun
Abstract excerpt
CYP2D6 metabolizes nearly 25% of clinically used drugs. Genetic polymorphisms cause large inter-individual variability in CYP2D6 enzyme activity and are currently used as biomarker to predict CYP2D6 metabolizer phenotype. Previously, we had identified a region 115 kb downstream of CYP2D6 as enhancer for CYP2D6, containing two completely linked single nucleotide polymorphisms (SNPs), rs133333 and rs5758550,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
